Ani Pharmaceuticals Revenue, Growth & Competitor Profile

DBA BIOSANTE PHARMACEUTICALS, INC.

Company Profile & Annual Report for Ani Pharmaceuticals

Access the complete profile.

Ani Pharmaceuticals Fast Facts

Revenue	Over $500 million    See Exact Annual Revenue
Employees	100 - 500Exact Company Size
Primary Industry	4242 Drugs & Druggists' Sundries Merchant Wholesalers
Additional NAICS Codes	5417 Scientific Research & Development Services
Address	210 Main Street Baudette, MN 56623

Ani Pharmaceuticals's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Ani Pharmaceuticals's annual revenues are Over $500 million (see exact revenue data)
• What industry is the company in?
  • Ani Pharmaceuticals is classified as operating in the Drugs & Druggists' Sundries Merchant Wholesalers industry, NAICS Code 4242.

Ani Pharmaceuticals is a publicly traded company on NGM using the ticker symbol ANIP. Detailed information on company financials and operating reports can be found here: NGM: ANIP

Ani Pharmaceuticals Annual Revenue and Growth Rate

Ani Pharmaceuticals	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	Over $500 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Ani Pharmaceuticals's revenues are gauged from an analysis of company filings.

Trademark Applications

Trademark applications show the products and services that Ani Pharmaceuticals is developing and marketing. Ani Pharmaceuticals's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
INZIRQO Pharmaceutical preparations for the treatment of oncological and cardiovascular diseases, hypertension, renal disorders and arthritis; Pharmaceutical preparations for the treatment of infectious diseases and auto-immune diseases	03/08/2023
OPFLOVA Pharmaceutical preparations for the treatment of oncological and cardiovascular diseases, hypertension, renal disorders and arthritis; Pharmaceutical preparations for the treatment of infectious diseases and auto-immune diseases	03/02/2023
SOVUNA Pharmaceutical preparations for the treatment of oncological and cardiovascular diseases, hypertension, renal disorders and arthritis; Pharmaceutical preparations for the treatment of infectious diseases and auto-immune diseases	02/23/2023

See all trademarks and details in the Full Report.

Market Share of Ani Pharmaceuticals's Largest Competitors

A competitive analysis shows these companies are in the same general field as Ani Pharmaceuticals, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
AMERISOURCEBERGEN	Conshohocken, PA	100
MCKESSON	Irving, TX	58
CARDINAL HEALTH 119	Dublin, OH	42
TAKEDA PHARMACEUTICALS AMERICA	Lexington, MA	31
CATALENT PHARMA SOLUTIONS	Somerset, NJ	13
OWENS & MINOR DISTRIBUTION	Mechanicsville, VA	11
J M SMITH	Spartanburg, SC	3
DAIICHI SANKYO	Basking Ridge, NJ	3
HIKMA PHARMACEUTICALS USA	Berkeley Heights, NJ	2

Nearby Competitors

These companies are similar in business line and location to Ani Pharmaceuticals. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
ANIP ACQUISITIONS D/B/A ANI PHARMACEUTICALS	Baudette, MN	100
ANI PHARMACEUTICALS	Baudette, MN	40
RAINY LAKE OIL	International Falls, MN	3
CANTILEVER BRIDGE DISTILLERY	Ranier, MN	2
NEI BOTTLING	Bemidji, MN	2
COCA COLA BOTTLING	International Falls, MN	1
COCA COLA BOTTLING COMPANY OF BEMIDJI	Bemidji, MN	1

Future Competition: Ani Pharmaceuticals's Fastest Growing Competitors

These companies are in the same general field as Ani Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)